23-Apr-2024
TipRanks (Mon, 22-Apr 1:51 AM ET)
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks (Fri, 19-Apr 7:40 AM ET)
AdaptHealth Corp. Announces First Quarter 2024 Earnings Release Date and Conference Call
Business Wire (Thu, 18-Apr 8:00 AM ET)
AdaptHealth Appoints Suzanne Foster as Chief Executive Officer
Business Wire (Wed, 17-Apr 4:15 PM ET)
Globe Newswire (Thu, 21-Mar 9:00 PM ET)
AdaptHealth Corp. to Participate in the Barclays 26th Annual Global Healthcare Conference
Business Wire (Mon, 4-Mar 4:05 PM ET)
AdaptHealth Corp. to Participate in the 3rd Annual Jefferies Value Based Care Summit
Business Wire (Fri, 1-Mar 8:00 AM ET)
Business Wire (Tue, 27-Feb 7:00 AM ET)
Business Wire (Thu, 8-Feb 4:05 PM ET)
Globe Newswire (Wed, 7-Feb 9:00 AM ET)
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.
Adapthealth Corp. trades on the NASDAQ stock market under the symbol AHCO.
As of April 23, 2024, AHCO stock price climbed to $9.81 with 936,095 million shares trading.
AHCO has a beta of 2.34, meaning it tends to be more sensitive to market movements. AHCO has a correlation of 0.17 to the broad based SPY ETF.
AHCO has a market cap of $1.34 billion. This is considered a Small Cap stock.
Last quarter Adapthealth Corp. reported $858 million in Revenue and $.49 earnings per share. This beat revenue expectation by $33 million and exceeded earnings estimates by $.31.
In the last 3 years, AHCO stock traded as high as $31.14 and as low as $6.37.
The top ETF exchange traded funds that AHCO belongs to (by Net Assets): IJR, VTI, VB, IWM, VXF.
AHCO has underperformed the market in the last year with a price return of -19.9% while the SPY ETF gained +24.3%. However, in the short term, AHCO had mixed performance relative to the market. It has outperformed in the last 3 months, returning +40.1% vs +4.6% return in SPY. But in the last 2 weeks, AHCO shares have been beat by the market, returning -5.7% compared to an SPY return of -2.6%.
AHCO support price is $9.28 and resistance is $9.92 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AHCO stock will trade within this expected range on the day.